The Hinge peptide (KDYIRN), which represents the dimerization domain of HGF, was included as a positive control
Clinical chemistry and hematology parameters remain within normal ranges across dose levels and treatment durations
Current safety data for 5-amino-1MQ appears favorable for short-term use (8-12 week cycles), with no significant toxicity observed in preclinical studies at therapeutic doses
However, like all research peptides, it must be used only in non-human laboratory settings , and should never be promoted or interpreted as a therapeutic product
10.1089/acm.2006.12.881 [DOI] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article
Just one of these vitamin B12 tablets daily will provide a high-potency dose of vitamin B12 to support healthy bodily functions and energy levels